CBUS Q1 2026 Earnings Call Summary

Cibus Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Cash Position: As of March 31, 2026, cash and cash equivalents totaled $30.3 million.
Capital Raised: Approximately $37 million in gross proceeds from two public offerings.
Operating Expenses:
- Research and Development (R&D) expenses decreased to $8.7 million from $11.8 million year-over-year.
- Selling, General and Administrative (SG&A) expenses fell to $5.1 million from $9.9 million, primarily due to reduced litigation costs and cost-saving initiatives.
Net Loss: Reported a net loss of $21.2 million, significantly improved from $49.4 million in the prior year, resulting in a loss per share of $0.33 compared to $1.34.
Annual Cash Usage Target: Aiming for net cash usage of approximately $30 million or less for 2026.

2. Strategic Updates and Business Highlights

Commercial Focus: Emphasis on executing commercial opportunities, particularly in rice and sustainable ingredients.
Rice Program:
- Seven active customer relationships in rice across Latin America and the U.S.
- Delivery of gene-edited rice to Interoc marks significant progress towards commercialization.
- Planned LATAM commercial launch in 2027, with U.S. launch delayed from 2028 to 2029 due to herbicide registration issues.
Sustainable Ingredients:
- Progressing towards commercial scale production of biofragrances, with expected scale-up orders in the second half of 2026.
- Potential annual royalty opportunity from biofragrance partnerships estimated between $20 million and $40 million.
Regulatory Environment: Positive developments in regulatory frameworks in the EU and Latin America, facilitating commercialization.

3. Forward Guidance and Outlook

Revenue Expectations: Anticipating initial commercial revenue from sustainable ingredients in 2026, with a ramp-up expected in 2027.
Operational Focus: Continued emphasis on executing commercial agreements and advancing regulatory processes to support product launches.

4. Challenges and Points of Concern

U.S. Rice Launch Delay: The herbicide registration process has pushed back the U.S. launch timeline, which may impact revenue expectations.
Market Conditions: Global fertilizer supply chain disruptions create challenges for farmers, which could affect demand for Cibus’s products.
Burn Rate Management: While the company aims to reduce its burn rate, the transition from reorganization may lead to fluctuations in expenses in the near term.

5. Notable Q&A Insights

Sustainable Ingredients Expansion: The amendment to the contract with the Sustainable Ingredients partner focuses on soybean oleic oils, indicating a growing revenue stream.
Burn Rate Projections: Management expects the burn rate to decrease in the latter half of 2026 as cost-saving measures take effect.
Commercialization Strategy: The focus remains on Latin America for rice commercialization, with the U.S. market being secondary but still important due to higher dollar per acre potential.
Fragrance Product Details: While specific product formulations for biofragrances have not been disclosed, the company is actively working on scaling production and finalizing agreements.

Overall, Cibus is positioned for growth with a clear focus on commercial execution and regulatory advancements, despite facing some challenges related to market conditions and specific product launch timelines.

CBUS — Cibus, Inc.